SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 127 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $11,336,000 | -13.8% | 116,228 | -18.0% | 0.01% | -12.5% |
| Q4 2014 | $13,155,000 | +35.1% | 141,773 | +0.1% | 0.01% | +33.3% |
| Q3 2014 | $9,738,000 | -42.3% | 141,593 | -12.1% | 0.01% | -40.0% |
| Q2 2014 | $16,874,000 | +54.3% | 161,013 | +22.2% | 0.01% | +42.9% |
| Q1 2014 | $10,934,000 | +31.9% | 131,784 | +2.9% | 0.01% | +40.0% |
| Q4 2013 | $8,287,000 | -3.8% | 128,040 | -5.9% | 0.01% | -16.7% |
| Q3 2013 | $8,614,000 | +78.9% | 136,065 | +18.7% | 0.01% | +100.0% |
| Q2 2013 | $4,815,000 | – | 114,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |